# A Study of LY3484356 in Healthy Female Participants

> **NCT04840888** · PHASE1 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 82 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** LY3484356
- **DRUG:** Omeprazole
- **DRUG:** Itraconazole
- **DRUG:** Carbamazepine
- **DRUG:** Midazolam

## Key facts

- **NCT ID:** NCT04840888
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-04-26
- **Primary completion:** 2022-04-12
- **Final completion:** 2022-04-12
- **Target enrollment:** 82 (ACTUAL)
- **Last updated:** 2025-12-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04840888

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04840888, "A Study of LY3484356 in Healthy Female Participants". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04840888. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*